MediPharm Posts Q1 2021 Results: What Cannabis Stock Investors Need To Know

MediPharm Labs Corp. LABS MEDIF MLZ reported Monday its first-quarter revenue amounted to CA$5.49 million ($4.53 million), down by roughly 9% sequentially and 50% year-over-year.

Adjusted EBITDA, a non-IFRS measure, came in negative at roughly CA$6.16 million, representing an improvement from a CA$8.77 million loss in the prior quarter and a loss of CA$5.66 million in the same quarter of 2020.

Greg Hunter, CFO of the Barrie, Ontario-based company, called the quarter a "cross-over period to our future state as the preferred global cannabis API provider to medical and wellness markets."

Q1 2021 Highlights

  • Gross profit was negative at CA$680 000 compared to a negative gross profit of CA$24.7 million in the previous quarter and CA$10.9 million in the same period of 2020.
  • A negative gross margin was 12%, compared to a negative gross margin of 408% in the last three months of 2020 and 98% in the prior year's corresponding quarter.
  • Net loss amounted to approximately CA$13.9 million, after shrinking by 55% sequentially and 37% year-over-year.
  • International sales rose to CA$1.8 million over the last three months of 2020, to CA$2.1 million in the first quarter of 2021.
  • The company achieved more than CA$1.5 million in cost savings.
  • As of March 31, the company had CA$42.1 million in cash and cash equivalents.

"We commenced 2021 focused on establishing our presence as a pharmaceutical company while ramping up and significantly growing our international sales," Hunter added.

In October, MediPharm Labs inked a deal to supply GMP-certified medical cannabis products to German pharmaceutical giant Stada Arzneimittel AG.

Six months later, in April, the company expanded its reach in the German market by signing a two-year supply agreement with the subsidiary of the multi-country medical and recreational cannabis operator IM Cannabis IMCC IMCC, which agreed to expand its product offering in Germany in 2021.

Photo by Diyahna Lewis on Unsplash

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsPenny StocksMarkets
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on – Prices will increase very soon!